The Enterprise Value as of November 2024 (TTM) for Century Therapeutics, Inc. (IPSC) is 104.89M

According to Century Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 104.89M. This represents a change of -48.28% compared to the average of 202.81M of the last 4 quarters.

Century Therapeutics, Inc. (IPSC) Historical Enterprise Value (quarterly & annually)

How has IPSC Enterprise Value performed in the past?

The mean historical Enterprise Value of Century Therapeutics, Inc. over the last ten years is 750.44M. The current 104.89M Enterprise Value has changed 1.30% with respect to the historical average. Over the past ten years (40 quarters), IPSC's Enterprise Value was at its highest in in the June 2021 quarter at 1.35B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Century Therapeutics, Inc. (IPSC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Century Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Century Therapeutics, Inc. (IPSC) Average Enterprise Value

How has IPSC Enterprise Value performed in the past?

The current Enterprise Value of Century Therapeutics, Inc. (IPSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Century Therapeutics, Inc. (IPSC) Enterprise Value vs. Peers

How is IPSC’s Enterprise Value compared to its peers?

Century Therapeutics, Inc.’s Enterprise Value is less than Edgewise Therapeutics, Inc. (3.01B), less than C4 Therapeutics, Inc. (307.45M), less than Mineralys Therapeutics, Inc. (523.81M), less than Cullinan Oncology, Inc. (630.54M), greater than Passage Bio, Inc. (24.72M), greater than Homology Medicines, Inc. (-103303255.00), less than Generation Bio Co. (163.63M), less than Stoke Therapeutics, Inc. (457.69M), less than Erasca, Inc. (747.42M), greater than NGM Biopharmaceuticals, Inc. (69.72M), less than Keros Therapeutics, Inc. (1.75B), less than Monte Rosa Therapeutics, Inc. (439.72M), greater than Kezar Life Sciences, Inc. (36.78M), less than Nkarta, Inc. (201.38M), less than Theseus Pharmaceuticals, Inc. (138.26M), less than aTyr Pharma, Inc. (138.44M), less than Relay Therapeutics, Inc. (692.53M), less than Blueprint Medicines Corporation (6.36B),

Build a custom stock screener for Century Therapeutics, Inc. (IPSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Century Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Century Therapeutics, Inc. (IPSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Century Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.